GlassScriptPhysician profile
Peter P Mckeown
NPI 1699737494
$4,093.48
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,567 · 2020: $493 · 2021: $33.37.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,697.99 | 2019-2020 | |
| Abiomed | $577.49 | 2019-2020 | |
| Abbott Laboratories | $209.49 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.06 | 2019-2021 | |
| Baxter Healthcare | $118.75 | 2020 | |
| Kci USA, INC. | $82.54 | 2019 | |
| Edwards Lifesciences Corporation | $74.97 | 2019-2020 | |
| Atricure, INC. | $31.17 | 2019-2021 | |
| Stryker Corporation | $21.04 | 2020 | |
| Circassia INC. | $19.12 | 2020 | |
| Zimmer Biomet Holdings, INC. | $17.97 | 2019 | |
| Artivion, INC. | $16.97 | 2020 | |
| Kls-Martin L.P. | $16.60 | 2020 | |
| Ethicon US, LLC | $14.42 | 2020 | |
| Davol INC. | $13.49 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Access Systems, INC. | $13.33 | 2019 | |
| Cook Medical LLC | $12.83 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mckeown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.